2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Sunday, November 8, 2015

9:00AM-11:00AM: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster I

9:00AM-11:00AM: Epidemiology and Public Health Poster I: Comorbidities and Outcomes of Systemic Inflammatory Diseases

9:00AM-11:00AM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

9:00AM-11:00AM: Genetics, Genomics and Proteomics Poster I

9:00AM-11:00AM: Health Services Research Poster I: Diagnosis, Management and Treatment Strategies

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

9:00AM-11:00AM: Innate Immunity and Rheumatic Disease Poster I

9:00AM-11:00AM: Metabolic and Crystal Arthropathies Poster I

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster

9:00AM-11:00AM: Osteoarthritis - Clinical Aspects Poster I: Treatments and Metabolic Risk Factors

9:00AM-11:00AM: Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis Poster

9:00AM-11:00AM: Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster I: Lupus, Scleroderma, JDMS

9:00AM-11:00AM: Rheumatoid Arthritis - Clinical Aspects Poster I

9:00AM-11:00AM: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster I

9:00AM-11:00AM: Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy

9:00AM-11:00AM: Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster I

9:00AM-11:00AM: Sjögren's Syndrome Poster I: Clinical Insights into Sjögren's Syndrome

9:00AM-11:00AM: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments

9:00AM-11:00AM: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session I

9:00AM-11:00AM: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster I

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I

9:00AM-11:00AM: Vasculitis Poster I

11:00AM-12:30PM: ACR Plenary Session I: Discovery 2015

2:30PM-4:00PM: ARHP I: Exemplary Abstracts

2:30PM-4:00PM: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

2:30PM-4:00PM: Epidemiology and Public Health I: RA Comorbidities and Mortality

2:30PM-4:00PM: Fibromyalgia: Insights Into Diagnostic Criteria and Symptom Epidemiology

2:30PM-4:00PM: Health Services Research I: Digital Health and Patient, Provider Factors in Rheumatic Disease

2:30PM-4:00PM: Imaging of Rheumatic Diseases I: Ultrasound

2:30PM-4:00PM: Innate Immunity and Rheumatic Disease

2:30PM-4:00PM: Miscellaneous Rheumatic and Inflammatory Diseases I

2:30PM-4:00PM: Muscle Biology, Myositis and Myopathies I

2:30PM-4:00PM: Osteoarthritis - Clinical Aspects: Treatments and Epidemiology

2:30PM-4:00PM: Pediatric Rheumatology - Clinical and Therapeutic Aspects I: Juvenile Idiopathic Arthritis

2:30PM-4:00PM: Rheumatoid Arthritis - Human Etiology and Pathogenesis I

2:30PM-4:00PM: Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy I: Biologics

2:30PM-4:00PM: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Treatment of AS

2:30PM-4:00PM: Spondylarthropathies Psoriatic Arthritis - Pathogenesis, Etiology

2:30PM-4:00PM: Systemic Lupus Erythematosus - Clinical Aspects and Treatment I: Epidemiology and Prognosis

2:30PM-4:00PM: T cell Biology and Targets in Autoimmune Disease I

4:30PM-6:00PM: ACR/ARHP Combined Abstract Session: Rehabilitation

4:30PM-6:00PM: Education

4:30PM-6:00PM: Osteoarthritis - Clinical Aspects I: Imaging and Epidemiology

4:30PM-6:00PM: Pain: Basic Aspects

4:30PM-6:00PM: Pediatric Rheumatology - Pathogenesis and Genetic

4:30PM-6:00PM: Quality Measures and Quality of Care

4:30PM-6:00PM: Rheumatoid Arthritis - Animal Models I

4:30PM-6:00PM: Rheumatoid Arthritis - Clinical Aspects I - Treatment Advances and Strategies

4:30PM-6:00PM: Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy II: Small Molecular Targeted Therapies

4:30PM-6:00PM: Sjögren's Syndrome I: Basic Insights

4:30PM-6:00PM: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Clinical Aspects and CoMorbidities

4:30PM-6:00PM: Systemic Lupus Erythematosus - Clinical Aspects and Treatment II: Patient-Reported Measures, Outcomes and Reporting

4:30PM-6:00PM: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Genetics, Gene Expression, and Epigenetics

4:30PM-6:00PM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's - Clinical Aspects and Therapeutics I

4:30PM-6:00PM: Vasculitis I

Monday, November 9, 2015

9:00AM-11:00AM: B cell Biology and Targets in Rheumatolid Arthritis and other Autoimmune Disease Poster

9:00AM-11:00AM: Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis

9:00AM-11:00AM: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

9:00AM-11:00AM: Education Poster (ARHP): Education/Community Programs

9:00AM-11:00AM: Education Poster I

9:00AM-11:00AM: Epidemiology and Public Health Poster II: Pathogenesis and Treatment of Systemic Inflammatory Diseases

9:00AM-11:00AM: Genetics, Genomics and Proteomics Poster II

9:00AM-11:00AM: Health Services Research Poster (ARHP)

9:00AM-11:00AM: Health Services Research Poster II (ACR): Healthcare Access, Patterns of Medication Use and Workforce Considerations

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT

9:00AM-11:00AM: Infection-related Rheumatic Disease: Poster Session

9:00AM-11:00AM: Innate Immunity and Rheumatic Disease Poster II

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster Session II

9:00AM-11:00AM: Orthopedics, Low Back Pain and Rehabilitation Poster

9:00AM-11:00AM: Pain: Basic and Clinical Aspects Poster

9:00AM-11:00AM: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases

9:00AM-11:00AM: Quality Measures and Quality of Care Poster Session (ARHP): Clinical Practice/Patient Care

9:00AM-11:00AM: Rheumatoid Arthritis - Clinical Aspects Poster II

9:00AM-11:00AM: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster II

9:00AM-11:00AM: Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster II

9:00AM-11:00AM: Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II

9:00AM-11:00AM: Systemic Lupus Erythematosus - Animal Models Poster I

9:00AM-11:00AM: Systemic Lupus Erythematosus - Animal Models Poster II

9:00AM-11:00AM: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session II

9:00AM-11:00AM: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster I

9:00AM-11:00AM: T cell Biology and Targets in Autoimmune Disease Poster I

9:00AM-11:00AM: Vasculitis Poster II

11:00AM-12:30PM: ACR Plenary Session II: Discovery 2015

2:30PM-4:00PM: Antiphospholipid Syndrome: Recent findings

2:30PM-4:00PM: ARHP II: Lupus

2:30PM-4:00PM: Biology and Pathology of Bone and Joint: Ostearthritis Pathogenesis

2:30PM-4:00PM: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis II

2:30PM-4:00PM: Epidemiology and Public Health II: RA and Lifestyle Factors

2:30PM-4:00PM: Imaging of Rheumatic Diseases II: MRI, PET and CT

2:30PM-4:00PM: Infection-related Rheumatic Disease

2:30PM-4:00PM: Miscellaneous Rheumatic and Inflammatory Diseases Oral Session II

2:30PM-4:00PM: Pediatric Rheumatology - Clinical and Therapeutic Aspects II: Pediatric Systemic Lupus Erythematosus

2:30PM-4:00PM: Rheumatoid Arthritis - Clinical Aspects II: Infection, Malignancy and Other Comorbidites in RA

2:30PM-4:00PM: Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy III: Biosimilars

2:30PM-4:00PM: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Clinical Aspects

2:30PM-4:00PM: Systemic Lupus Erythematosus - Clinical Aspects and Treatment III: Biomarkers

2:30PM-4:00PM: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Modulators of Disease

4:30PM-6:00PM: ACR/ARHP Combined Abstract Session: Epidemiology and Pubic Health

4:30PM-6:00PM: ARHP III: Epidemiology and Public Health

4:30PM-6:00PM: Biology and Pathology of Bone and Joint: Bone Remodeling

4:30PM-6:00PM: Epidemiology and Public Health III: Risk Factors, Treatment and Outcomes of Gout and OA

4:30PM-6:00PM: Genetics, Genomics and Proteomics

4:30PM-6:00PM: Health Services Research II: Rheumatoid Arthritis Treatment and Healthcare Utilization

4:30PM-6:00PM: Metabolic and Crystal Arthropathies I: Therapeutics

4:30PM-6:00PM: Orthopedics, Low Back Pain and Rehabilitation

4:30PM-6:00PM: Reproductive Issues in Rheumatic Disorders: Basic and Clinical Aspects

4:30PM-6:00PM: Rheumatoid Arthritis - Clinical Aspects III - Cardiovascular Disease and RA

4:30PM-6:00PM: Rheumatoid Arthritis - Human Etiology and Pathogenesis II

4:30PM-6:00PM: Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy IV: Safety of Targeted Therapies

4:30PM-6:00PM: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment:Treatment of PsA and SpA

4:30PM-6:00PM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics I

4:30PM-6:00PM: Vasculitis II

Tuesday, November 10, 2015

9:00AM-11:00AM: ACR Late-breaking Abstract Poster Presentations

9:00AM-11:00AM: Antiphospholipid Syndrome: Basic Science

9:00AM-11:00AM: Antiphospholipid Syndrome: Clinical

9:00AM-11:00AM: Biology and Pathology of Bone and Joint: Bone Remodeling and Metabolism

9:00AM-11:00AM: Education Poster II

9:00AM-11:00AM: Epidemiology and Public Health Poster (ARHP)

9:00AM-11:00AM: Epidemiology and Public Health Poster III (ACR): Gout and Non-Inflammatory Musculoskeletal Conditions

9:00AM-11:00AM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II

9:00AM-11:00AM: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

9:00AM-11:00AM: Metabolic and Crystal Arthropathies Poster II

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster II: Autoantibodies and Treatments in Inflammatory Myopathies

9:00AM-11:00AM: Orthopedics, Low Back Pain and Rehabilitation Poster (ARHP): Rehabilitation Sciences

9:00AM-11:00AM: Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research

9:00AM-11:00AM: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters (ACR): Imaging and Novel Clinical Interventions

9:00AM-11:00AM: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters (ARHP): Pediatrics

9:00AM-11:00AM: Pediatric Rheumatology - Pathogenesis and Genetics Poster

9:00AM-11:00AM: Psychology/Social Sciences (ARHP)

9:00AM-11:00AM: Quality Measures and Quality of Care Poster Session

9:00AM-11:00AM: Reproductive Issues in Rheumatic Disorders: Basic and Clinical Aspects Poster Session

9:00AM-11:00AM: Research Methodology Poster (ARHP)

9:00AM-11:00AM: Rheumatoid Arthritis - Animal Models Poster

9:00AM-11:00AM: Rheumatoid Arthritis - Clinical Aspects Poster Session III

9:00AM-11:00AM: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III

9:00AM-11:00AM: Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster III

9:00AM-11:00AM: Sjögren's Syndrome: Translational Insights into Sjögren's Syndrome

9:00AM-11:00AM: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster III: Therapy

9:00AM-11:00AM: Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II

9:00AM-11:00AM: Spondylarthropathies and Psoriatic Arthritis Pathogenesis, Etiology Poster I

9:00AM-11:00AM: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II

9:00AM-11:00AM: T cell Biology and Targets in Autoimmune Disease Poster II

9:00AM-11:00AM: Vasculitis Poster III

11:00AM-12:30PM: ACR Plenary Session III: Discovery 2015

2:30PM-4:00PM: 2015 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lectureship

2:30PM-4:00PM: ACR/ARHP Combined Abstract Session: Pediatric Rheumatology

2:30PM-4:00PM: Fibromyalgia: Clinical Issues

2:30PM-4:00PM: Pediatric Rheumatology - Clinical and Therapeutic Aspects III: Miscellaneous Pediatric Rheumatic Diseases

2:30PM-4:00PM: Rheumatoid Arthritis - Clinical Aspects IV: Biomarkers, Disease Progression and Treatment Response

2:30PM-4:00PM: Rheumatoid Arthritis - Human Etiology and Pathogenesis III

2:30PM-4:00PM: Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy V: Immunogenecity

2:30PM-4:00PM: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Psoriatic Arthritis - CoMorbidities

2:30PM-4:00PM: Systemic Lupus Erythematosus - Clinical Aspects and Treatment V: Neuropsychiatric Lupus

2:30PM-4:00PM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics II

2:30PM-4:00PM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's - Clinical Aspects and Therapeutics II

2:30PM-4:00PM: Vasculitis III

4:30PM-6:00PM: ACR Late-breaking Abstract Session

4:30PM-6:00PM: ARHP IV: Clinical Practice and Patient Care

4:30PM-6:00PM: B cell Biology and Targets in Autoimmune Disease: Novel B cell roles in RA and SLE

4:30PM-6:00PM: Epidemiology and Public Health IV: Risk Factors and Comorbidities for SLE and Psoriatic Arthritis

4:30PM-6:00PM: Metabolic and Crystal Arthropathies II: Mechanisms and Associations

4:30PM-6:00PM: Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis

4:30PM-6:00PM: Pediatric Rheumatology - Clinical and Therapeutic Aspects IV: Imaging and Novel Clinical Interventions

4:30PM-6:00PM: Rheumatoid Arthritis - Clinical Aspects V: Goal = Remission

4:30PM-6:00PM: Rheumatoid Arthritis Animal Models II

4:30PM-6:00PM: Rheumatoid Arthritis-Small Molecules, Biologics and Gene Therapy VI: Strategies

4:30PM-6:00PM: Sjögren's Syndrome II: Clinical Discoveries

4:30PM-6:00PM: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Clinical Aspects, Imaging and Biomarkers

4:30PM-6:00PM: Systemic Lupus Erythematosus - Animal Models

4:30PM-6:00PM: Systemic Lupus Erythematosus - Clinical Aspects and Treatment VI: Novel Therapies

4:30PM-6:00PM: Vasculitis IV

Wednesday, November 11, 2015

9:00AM-10:30AM: ARHP V: Physical Activity

9:00AM-10:30AM: Rheumatoid Arthritis - Clinical Aspects VI: Death Be Not Proud-Mortality and Treatment Outcomes in RA (Includes 2014 Lee C. Howley, Sr. Prize for Arthritis Research Introductory Talk)

11:00AM-12:30PM: ARHP VI: Physical Function and Disability

11:00AM-12:30PM: Pain: Clinical Aspects

11:00AM-12:30PM: Rheumatoid Arthritis - Clinical Aspects VII: Disease Activity and Updates in Measurement

11:00AM-12:30PM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's - Clinical Aspects and Therapeutics III

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].